Abstract
The present study was designed to clarify whether bcl-xL is involved in the development of carcinoma in the stomach. Levels of bcl-xL and bcf-2 mRNA were determined by a reversetranscription/polymerase-chain reaction in endoscopic gastric biopsy specimens from 10 control subjects, 11 patients with adenomas and 14 patients with carcinomas. In 6 of 11 adenomas, 5 of 8 early carcinomas and 3 of 6 advanced carcinomas, the bcl-xL gene was over-expressed. In carcinomas, over-expression of the bcl-xL gene was observed in 6 of 9 intestinal-type carcinomas and 2 of 5 diffuse-type carcinomas. No correlation was observed between bcl-xL and bcl-2 gene expression. In cases in which the bcl-xL gene was over-expressed, an apparent increase in the protein level of BcI-X1. was observed by immunoblot analysis and intense Bcl-x immunoreactivity was detected immunohistochemically within the tumor cells. In conclusion, we showed that bcl-xL is over-expressed in gastric carcinomas at both the RNA and protein levels, suggesting that over-expression of bcl-xL may play a role in gastric carcinogenesis. © 1996 Wiley-Liss, Inc.
Cite
CITATION STYLE
Kondo, S., Shinomura, Y., Kanayama, S., Higashimoto, Y., Miyagawa, J. I., Minami, T., … Matsuzawa, Y. (1996). Over-expression of bcl-xL gene in human gastric adenomas and carcinomas. International Journal of Cancer, 68(6), 727–730. https://doi.org/10.1002/(SICI)1097-0215(19961211)68:6<727::AID-IJC6>3.0.CO;2-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.